A technical view of four stocks that appear to be at or near a breakout point.
Currently enrolling Phase 3 patients for cord blood cell therapy with potential to be universal curative stem cell graft (Image: Gamida Cell)
Collaboration on 3 immuno-oncology programs
Company chart and information is provided by TradingView based on 15-minute-delayed data.
Pieris Pharmaceuticals Inc is a clinical-stage biopharmaceutical company, which engages in the discovery and development of Anticalin class of biotherapeutics. Anticalin proteins are engineered versions of lipocalins, human proteins that naturally bind, store and transport a wide spectrum of molecules. The company with the help of technology creates differentiated drugs such as PRS-080, PRS-060, PRS-343 and PRS-332 that can help patients suffering from cancer, severe asthma, anemia, and other medical conditions with a high unmet medical need. Geographically, all the operation of the firm is functioned through the region of United States.
| Website: | www.pieris.com |
| Email: | kelman@pieris.com |
| Main Phone: | +1 857 246-8998 |
| Address: | 255 State Street |
| Address 2: | 9th floor |
| State: | MA |
| City / Town: | Boston |
| Country: | US |
| Postal Code: | 02109 |
| Exchange: | NSC |
| CEO: | Stephen S. Yoder |
| Employees: | 127 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
A technical view of four stocks that appear to be at or near a breakout point.
Currently enrolling Phase 3 patients for cord blood cell therapy with potential to be universal curative stem cell graft (Image: Gamida Cell)
Collaboration on 3 immuno-oncology programs
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
